Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 1...

FDA Recall #D-0221-2025 — Class II — January 30, 2025

Recall #D-0221-2025 Date: January 30, 2025 Classification: Class II Status: Ongoing

Product Description

Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit dose blisters), Rx Only, Distributed by: Aurobindo Pharma USA< INC., 279 Princeton-Hightstown Road, East Windsor, NJ 08520. Made in India. Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152. NDC: 0904-7216-61

Reason for Recall

Failed Dissolution Specifications.

Recalling Firm

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — La Vergne, TN

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

6997 cartons

Distribution

Nationwide in the USA

Code Information

Lot# T05224; Exp. 02/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated